SEC Form 4 · accession 0001181431-15-000519
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey W Sherman
Officer — EVP & Chief Medical Officer
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary sharesF1 | Jan 2, 2015 | M | 26,750 | $0.00 | A | 111,086 | D | |
| Ordinary sharesF2,F3 | Jan 2, 2015 | F | 8,753 | $12.80 | D | 102,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted stock unitsF1,F4 | — | Jan 2, 2015 | M | 11,250 | D | — | — | Ordinary shares | 33,750 | 22,500 | D |
| Restricted stock unitsF1,F5 | — | Jan 2, 2015 | M | 15,500 | D | — | — | Ordinary shares | 62,000 | 46,500 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Reflects the net settlement of ordinary shares of the Issuer in connection with the vesting of restricted stock units.
- F3Includes 4,485 ordinary shares of the Issuer acquired by the reporting person in December 2014 pursuant to an employee stock purchase program.
- F4On January 2, 2013, the reporting person was granted 45,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
- F5On January 2, 2014, the reporting person was granted 62,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.